Pharmaceuticals News and Research

RSS

Adolescent girls that have been physically coerced into sexual intercourse are more likely to have had a sexually transmitted disease

Adolescent girls who say they have been physically coerced into sexual intercourse are more likely to have had a sexually transmitted disease, according to a new study published in the journal Women’s Health Issues.

17 Aug 2004

Medical alternative to surgery for cataracts

A common age related cause of blindness is being studied by researchers in the Cataract Group of the Agricultural and Life Sciences Division at Lincoln University, New Zealand. They are working on finding out a medical alternative to surgery.

16 Aug 2004

Insomnia drug market will exceed $5.6 billion in 2013

The new Pharmacor study entitled Insomnia finds that upcoming launches of three new drugs from Sepracor, Pfizer, and Sanofi-Aventis will drive the market.

16 Aug 2004

The largest North American breast cancer prevention trial ever undertaken has reached its goal of enrolling 19,000 women

The largest North American breast cancer prevention trial ever undertaken, the Study of Tamoxifen and Raloxifene (STAR), reached its goal of enrolling 19,000 women to the trial in June 2004, a month earlier than originally expected.

13 Aug 2004

Drug company fights to keep toxin in vaccines

The UK announced Saturday they will remove the mercury preservative Thimerosal from their vaccines. The news comes days after an LA Times article reported that Aventis-Pasteur, a pharmaceutical giant, is pushing to keep the toxin in U.S. vaccines.

13 Aug 2004

New method for building carbohydrate molecules

Chemists at the California Institute of Technology have succeeded in devising a new method for building carbohydrate molecules in a simple and straightforward way that requires very few steps. The new synthesis strategy should be of benefit to scientists in the areas of chemistry and biology and in the pharmaceutical industry.

13 Aug 2004

Australian funding to assist with the investigation of clandestine laboratory operations

"Clandestine amphetamine laboratories have increased by 300 per cent and it is important that forensic experts have the opportunity to work together in what is one of the most important areas in the fight against illegal drugs," Senator Ellison said.

13 Aug 2004

Investigation into mTOR protein function is far from over

Discovery of the mTOR protein and the role it plays in cell growth, a process often linked to diseases such as cancer, was part serendipity and part good detective work. And like any good whodunit, the mTOR story wouldn’t be complete without an unexpected twist.

12 Aug 2004

John Kerry outlines plan to bring down the costs of prescription drugs

Armed with the endorsement of the Alliance for Retired Americans, Democratic Presidential nominee John Kerry Wednesday outlined his plan to bring down the costs of prescription drugs as part of his overall plan to make health care more affordable for all Americans.

11 Aug 2004

New biotech alliance to focus on diseases of nerve injury and pain

NeuroTargets Ltd, a discovery-led biotechnology company ‘spun-out’ from the University of Bristol, has formed an exciting new alliance with BioFocus plc, a world leader in collaborative drug discovery, to focus on diseases of nerve injury and pain.

11 Aug 2004

Scientists identify compounds that mimic calorie restriction

Investigators from an international consortium of research institutes, including the Johns Hopkins Bloomberg School of Public Health, have identified compounds that mimic the effects of a low calorie diet without changing the amount of essential nutrients.

11 Aug 2004

Significant differences between men and women when it comes to identifying the cause of back pain

A new survey of physicians who regularly treat back pain, the second most common reason people visit a doctor, reveals that there are significant differences between men and women when it comes to identifying the causes of their discomfort.

11 Aug 2004

IBM and Cellomics offer new solution to accelerate cell-based drug discovery

IBM and Cellomics have announced they have launched a customized information technology (IT) solution that allows biopharmaceutical scientists and academic researchers to better understand how potential drug candidates or targets of interest affect cellular function.

11 Aug 2004

Choice Media acquires three health portals

Choice Media one of the largest healthcare information networks on the Internet, and its wholly owned subsidiary, MDChoice.com have acquired three health portals, reaching millions of additional health-minded consumers each year.

11 Aug 2004

Elderly people in the U.S. are being inappropriately prescribed medications

In the U.S. only 15 percent of the population is aged 65 years or older, but this group account for 33 percent of prescription drug users. Elderly persons are also more likely to take several drugs concurrently, the article states.

10 Aug 2004

Effects of oxidative stress on atherosclerosis

Heart disease and stroke are the first and third leading causes of death among men and women in the United States and account for 40 percent of all mortalities, according to the Centers for Disease Control and Prevention.

9 Aug 2004

Promising families of drugs combat the spread of tumors in different ways

Pharmaceutical companies seeking to design more effective cancer chemotherapy agents may have an easier road ahead than was previously believed.

9 Aug 2004

Total global market for oligonucleotides is likely to grow from USD 340.0 million in 2003 to USD 776.0 million in 2010

Poised on the brink of phenomenal growth, the oligonucleotides market offers a plethora of opportunities to the enterprising investor. Recent analysis by Frost & Sullivan estimates that the total global market for oligonucleotides is likely to grow from USD 340.0 million in 2003 to USD 776.0 million in 2010.

9 Aug 2004

Promising new cancer drug, Nanotax

A Lawrence company that uses patented technology created at the University of Kansas to improve the effectiveness of drugs has won a $100,000 National Institutes of Health grant to support further testing of the company's promising new cancer drug, Nanotax.

5 Aug 2004

Mayo Clinic and IBM have announced a broad collaboration to accelerate advances in patient care and research

Mayo Clinic and IBM have announced a broad collaboration to accelerate advances in patient care and research with an aggressive set of technology initiatives. The goal is to take advantage of an explosion in new medical data to drive tighter linkage between research and the practice of medicine to achieve breakthroughs.

5 Aug 2004